Over the 90-day window ending December 17, 2025, Nuvectis Pharma's three dominant insider ownership positions are held by Chairman & CEO Ron Bentsur (3.53Mn shares), Director Matthew L. Kaplan (124.76K shares), Director Juan Sanchez (78.15K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Marlio Charles Mosseri | 5,748,576 | 16 Dec, 2024 | |
| Ron Bentsur | Chairman & CEO | 3,525,924 | 06 Nov, 2025 |
| Enrique Poradosu | Chief Science & Business Off | 1,656,319 | 03 Jan, 2025 |
| Shay Shemesh | Chief Dev. & Ops. Officer | 1,643,068 | 03 Jan, 2025 |
| Michael J. Carson | Vice President And Finance | 138,918 | 03 Jan, 2025 |
| Kenneth Hoberman | 133,140 | 12 Jun, 2025 | |
| Matthew L. Kaplan | 124,760 | 06 Nov, 2025 | |
| James F Iii Oliviero | 87,828 | 12 Jun, 2025 | |
| Juan Sanchez | 78,150 | 06 Nov, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 05 Nov, 2025 | Matthew L. Kaplan | Common Stock | A | 11,000 | $5.84 | 124,760 | D | P |
| 05 Nov, 2025 | Juan Sanchez | Common Stock | A | 13,000 | $5.79 | 78,150 | D | P |
| 05 Nov, 2025 | Ron Bentsur | Common Stock | A | 5,000 | $5.72 | 3,525,924 | D | P |
| 23 Oct, 2025 | Marlio Charles Mosseri | Common Stock | A | 46,900 | $6.06 | 3,028,706 | I | P |
| 24 Oct, 2025 | Marlio Charles Mosseri | Common Stock | A | 35,034 | $6.15 | 3,063,740 | I | P |
| 27 Oct, 2025 | Marlio Charles Mosseri | Common Stock | A | 72,836 | $6.28 | 3,136,576 | I | P |
| 22 Sep, 2025 | Juan Sanchez | Common Stock | A | 30,000 | $0.00 | 65,150 | D | A |
| 20 Jun, 2025 | Marlio Charles Mosseri | Common Stock | A | 5,603 | $7.99 | 2,981,806 | I | P |
| 20 Jun, 2025 | Marlio Charles Mosseri | - | - | 2,981,806 | I | |||
| 17 Jun, 2025 | Marlio Charles Mosseri | Common Stock | A | 5,399 | $8.11 | 2,948,160 | I | P |
| 18 Jun, 2025 | Marlio Charles Mosseri | - | - | 2,976,203 | I | |||
| 18 Jun, 2025 | Marlio Charles Mosseri | Common Stock | A | 28,043 | $8.05 | 2,976,203 | I | P |
| 12 Jun, 2025 | James F Iii Oliviero | Common Stock | A | 30,000 | $0.00 | 87,828 | D | A |
| 12 Jun, 2025 | James F Iii Oliviero | - | - | 87,828 | D | |||
| 12 Jun, 2025 | Matthew L. Kaplan | Common Stock | A | 30,000 | $0.00 | 113,760 | D | A |
| 12 Jun, 2025 | Kenneth Hoberman | Common Stock | A | 30,000 | $0.00 | 133,140 | D | A |
| 12 May, 2025 | Marlio Charles Mosseri | Common Stock | A | 21,167 | $8.11 | 2,942,761 | I | P |
| 06 May, 2025 | Marlio Charles Mosseri | Common Stock | A | 2,340 | $8.40 | 2,886,461 | I | P |
| 08 May, 2025 | Marlio Charles Mosseri | Common Stock | A | 100 | $8.99 | 2,909,032 | I | P |
| 06 May, 2025 | Marlio Charles Mosseri | Common Stock | A | 10,104 | $8.64 | 2,896,565 | I | P |